Northern Okla Pathology Cons is categorized under Pathological Laboratories in Ponca City, OK and active since 1979.
Northern Okla Pathology Cons was established in 1979, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Paul Gelvin, President at the company’s single location by writing to 400 Fairview Avenue # 12, Ponca City, Oklahoma OK 74601 or by phoning (580) 762-9129. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Northern Okla Pathology Cons |
| Contact Person: | Paul Gelvin, President |
| Address: | 400 Fairview Avenue # 12, Ponca City, Oklahoma 74601 |
| Phone Number: | (580) 762-9129 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6211110 |
| Share This Business: |
Northern Okla Pathology Cons was started in 1979 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Paul Gelvin, President for inquiries that concern Northern Okla Pathology Cons by calling the company number (580) 762-9129, as your correspondence is most welcome. Additionally, the physical location of the single location of Northern Okla Pathology Cons can be found at the coordinates 36.72521,-97.06987 as well as the street address 400 Fairview Avenue # 12 in Ponca City, Oklahoma 74601.
For its online presence, you may visit Northern Okla Pathology Cons’s website at and engage with its social media outlets through on Twitter and on Facebook.